tirzepatide psychological effects Men before and after tirzepatide: real results, timelines, and what to expect 20 Possible Tirzepatide Side Effects

Nutrition has a role in maintaining optimal blood supply to the brain

Recent Mergers & Acquisitions (M & A) 2025-2026: Mar 2026: BioMarin Pharmaceutical agreed to acquire rare disease biotech Amicus Therapeutics for $4.8B, strengthening metabolic & rare disease franchise overlap with diabetes-associated disorders Mar 2026: Sanofi entered $2.2B acquisition deal for Dynavax Technologies to expand vaccine and immunometabolic pipeline supporting diabetes-comorbidity therapeutics Jan 2026: Eli Lilly and Company announced acquisition of Ventyx Biosciences for $1.2B, expanding cardiometabolic and diabetes-related pipeline into immunology-linked therapies 2026 (closed/announced): Merck & Co

Studies have shown that many patients regain a significant portion of lost weight after discontinuing GLP-1 medications, highlighting the importance of sustainable lifestyle changes alongside pharmaceutical intervention

Inhibition and induction of glutathione S-transferases by flavonoids: possible pharmacological and toxicological consequences

Increased norepinephrine levels can promote satiety and reduce food intake, while higher dopamine levels may help control cravings and regulate reward pathways associated with food consumption

Overall, the 90% CIs of the ERs for AUC for all concomitant medications were within the pre-specified interval